Nouhravesh, N., Clare, R., Wojdyla, D., Anstrom, K. J., Velazquez, E., Greene, S., … Psotka, M. (2024). Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial. In European Heart Journal (Vol. 45). Oxford University Press (OUP). https://doi.org/10.1093/eurheartj/ehae666.1068

Nouhravesh, N., R. Clare, D. Wojdyla, K. J. Anstrom, E. Velazquez, S. Greene, B. Pitt, R. J. Mentz, and M. Psotka. “Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial.” In European Heart Journal, Vol. 45. Oxford University Press (OUP), 2024. https://doi.org/10.1093/eurheartj/ehae666.1068.

Nouhravesh N, Clare R, Wojdyla D, Anstrom KJ, Velazquez E, Greene S, et al. Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial. In: European Heart Journal. Oxford University Press (OUP); 2024.

Nouhravesh, N., et al. “Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial.” European Heart Journal, vol. 45, no. Supplement_1, Oxford University Press (OUP), 2024. Crossref, doi:10.1093/eurheartj/ehae666.1068.

Nouhravesh N, Clare R, Wojdyla D, Anstrom KJ, Velazquez E, Greene S, Pitt B, Mentz RJ, Psotka M. Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial. European Heart Journal. Oxford University Press (OUP); 2024.